Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer.
| Autor: | Chavez-MacGregor, Mariana, Miao, Jieling, Pusztai, Lajos, Goetz, Matthew P., Rastogi, Priya, Ganz, Patricia A., Mamounas, Eleftherios P., Paik, Soonmyung, Bandos, Hanna, Razaq, Wajeeha, O'Dea, Anne, Kaklamani, Virginia, Silber, Andrea L.M., Flaum, Lisa E., Andreopoulou, Eleni, Wendt, Albert G., Carney, Jennifer F., Sharma, Priyanka, Gralow, Julie R., Lew, Danika L. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 9/1/2024, Vol. 42 Issue 25, p3012-3021, 23p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|